UNSPSC 85877707: Fluoroscopy of corpora cavernosa using high osmolar contrast

This classification denotes the group of activities that yields a imaging intervention or procedure to fluoroscopy of corpora cavernosa using high osmolar contrast. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code BV100ZZ

UNSPSC 85877707 Fluoroscopy of corpora cavernosa using high osmolar contrast is a Commodity code showing minimal alignment between its nominal scope and recent state and local procurement activity. The code's name refers to a highly specific diagnostic imaging procedure, yet the recent opportunities posted under it span a broader range of healthcare delivery services with little connection to the procedure itself. State and local issuers using this code are procuring diagnostic imaging systems, ultrasound equipment, and clinical support services rather than the narrow fluoroscopy procedure the code nominally describes. The issuing bodies include county hospital systems, county health departments, and municipal police departments — a mix reflecting the wide net cast when procurement offices misalign opportunities with UNSPSC taxonomy.

Recent opportunities show activity across California and Florida, with one posting from New Mexico. San Mateo County, California, posted an RFP on July 9, 2026, for a Diagnostic Imaging Picture Archiving and Communication System (PACS) supporting radiology, cardiology, and dental imaging, with proposals due August 7, 2026, featuring a local preference of 5–10% under San Mateo County Ordinance Code Chapter 2.89. Collier County, Florida, issued a Notice of Intent on April 1, 2026, to single-source EchoNous, Inc., for ultrasound equipment and services without competitive bidding. The Albuquerque Police Department, New Mexico, posted an RFB on January 26, 2026, for on-call phlebotomy technician services with proposals due February 25, 2026. The code shows little relevant recent activity for the fluoroscopy procedure it nominally describes; firms evaluating this code should treat the mismatch as a signal to verify scope alignment before investing in opportunity evaluation.